Literature DB >> 8535782

Mechanistic implications from the structure of a catalytic fragment of Moloney murine leukemia virus reverse transcriptase.

M M Georgiadis1, S M Jessen, C M Ogata, A Telesnitsky, S P Goff, W A Hendrickson.   

Abstract

BACKGROUND: Reverse transcriptase (RT) converts the single-stranded RNA genome of a retrovirus into a double-stranded DNA copy for integration into the host genome. This process requires ribonuclease H as well as RNA- and DNA-directed DNA polymerase activities. Although the overall organization of HIV-1 RT is known from previously reported crystal structures, no structure of a complex including a metal ion, which is essential for its catalytic activity, has been reported.
RESULTS: Here we describe the structures at 1.8 Angstrum resolution of a catalytically active fragment of RT from Moloney murine leukemia virus (MMLV) and at 2.6 Angstrum of a complex of this fragment with Mn2+ coordinated in the polymerase active site. On the basis of similarities with HIV-1 RT and rat DNA polymerase beta, we have modeled template/primer and deoxyribonucleoside 5'-triphosphate substrates into the MMLV RT structure.
CONCLUSIONS: Our model, in the context of the disposition of evolutionarily conserved residues seen here at high resolution, provides new insights into the mechanisms of catalysis, fidelity, processivity and discrimination between deoxyribose and ribose nucleotides.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8535782     DOI: 10.1016/S0969-2126(01)00223-4

Source DB:  PubMed          Journal:  Structure        ISSN: 0969-2126            Impact factor:   5.006


  61 in total

1.  Analysis of mutations at positions 115 and 116 in the dNTP binding site of HIV-1 reverse transcriptase.

Authors:  P L Boyer; S G Sarafianos; E Arnold; S H Hughes
Journal:  Proc Natl Acad Sci U S A       Date:  2000-03-28       Impact factor: 11.205

2.  Analysis of mutations and suppressors affecting interactions between the subunits of the HIV type 1 reverse transcriptase.

Authors:  G Tachedjian; H E Aronson; S P Goff
Journal:  Proc Natl Acad Sci U S A       Date:  2000-06-06       Impact factor: 11.205

3.  Phenotypic characterization of three phylogenetically conserved stem-loop motifs in the mengovirus 3' untranslated region.

Authors:  H Duque; A C Palmenberg
Journal:  J Virol       Date:  2001-04       Impact factor: 5.103

4.  Template definition by Tetrahymena telomerase reverse transcriptase.

Authors:  M C Miller; J K Liu; K Collins
Journal:  EMBO J       Date:  2000-08-15       Impact factor: 11.598

5.  Structural determinants of murine leukemia virus reverse transcriptase that affect the frequency of template switching.

Authors:  E S Svarovskaia; K A Delviks; C K Hwang; V K Pathak
Journal:  J Virol       Date:  2000-08       Impact factor: 5.103

6.  Inhibition of the integrases of human immunodeficiency viruses type 1 and type 2 by reverse transcriptases.

Authors:  Iris Oz; Orna Avidan; Amnon Hizi
Journal:  Biochem J       Date:  2002-02-01       Impact factor: 3.857

7.  Crystal structure of the RNA-dependent RNA polymerase of hepatitis C virus.

Authors:  S Bressanelli; L Tomei; A Roussel; I Incitti; R L Vitale; M Mathieu; R De Francesco; F A Rey
Journal:  Proc Natl Acad Sci U S A       Date:  1999-11-09       Impact factor: 11.205

8.  The ribonuclease H activity of the reverse transcriptases of human immunodeficiency viruses type 1 and type 2 is modulated by residue 294 of the small subunit.

Authors:  Z Sevilya; S Loya; N Adir; A Hizi
Journal:  Nucleic Acids Res       Date:  2003-03-01       Impact factor: 16.971

9.  Development of an in vivo assay to identify structural determinants in murine leukemia virus reverse transcriptase important for fidelity.

Authors:  E K Halvas; E S Svarovskaia; V K Pathak
Journal:  J Virol       Date:  2000-01       Impact factor: 5.103

10.  Asymmetric subunit organization of heterodimeric Rous sarcoma virus reverse transcriptase alphabeta: localization of the polymerase and RNase H active sites in the alpha subunit.

Authors:  S Werner; B M Wöhrl
Journal:  J Virol       Date:  2000-04       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.